The production of the low-salt syndrome in cardiac patients with refractory congestive heart failure is generally attributed either to fluid retention with electrolyte dilution or to excessive salt loss, induced by the frequent administration of mercurial diuretics. The former is often the important etiologic factor. In a study of a group of 25 refractory cardiac patients with normal plasma electrolyte patterns, a hyperchloremic acidosis was produced to restore a responsiveness to mercurial diuretics. During the mercurial-induced diuresis that followed, the urinary sodium concentration was significantlv lower than the plasma sodium concentration in all instances. From these observations, a method of treatment of the low-salt syndrome, utilizing mercurial diuretics seemed feasible. This regimen was successfully carried out in two hyponatremic patients with return of plasma sodium to normal and striking clinical improvement.
IN cardiac patients with fluid retention, two types of electrolyte imbalance have been associated with a transient refractoriness to mercurial diuretics. One of these is hypochloremic alkalosis, and the other is hyponatremia in association with hypochloremia, the "low"-salt syndrome."
The former is a well-defined clinical entity' that sometimes occurs in the course of vigorous treatment of the edematous cardiac patient with salt restriction and protracted daily injections of a mercurial diuretic agent. Hypochloremic alkalosis may occur prior to the attainment of optimal body weight. Responsiveness to mercurial diuretics is restored in this situation when the hypochloremia is corrected by the administration of ammonium chloride.
The latter electrolyte imbalance, the "lowsalt syndrome," can be present in a number of From by Danowski and his associates2 who call them the "low-salt syndromes" and classify them according to total stores of extracellular sodium decreased, intact, and increased. The patients discussed in this article would fall into that group demonstrating the "low-salt syndrome" with increased sodium stores and congestive heart failure.
The "low-salt syndrome," as originally described by Schroeder3 consisted of (1) drowsiness, weakness, and lethargy, (2) loss of appetite, (3) nausea and vomiting and occasionally abdominal or muscular cramps. These symptoms occurred in a setting of (1) a successive depression of urinary volume, (2) decreased urinary excretion of chloride ion, not increasing after mercurial diuretic administration, (3) progressive gain in body weight, (4) rising nonprotein nitrogen content of the blood, and (5) hyponatremia and hypochloremia. The author reported two mechanisms by which this syndrome could be produced: by retention of water and dilution of electrolytes, and by excessive depletion of the body salt, usually associated with the use of mercurial diuretics. The former mechanism is well recognized, having been seen many times in postoperative surgical patients given parenteral glucose in water,4 and its significance as al etiologic factor in the production TREATMENT OF LOW-SALT SYNDROTME IN CONGESTIVEi HEART FAILUREI of the "low-salt syndrome" has received recognition.' 6 With regard to the latter mechanism, the question may be raised whether the data establish that mercurial diuretics contribute to the development of the clinical state described. In the original paper on the "low-salt syndome," only urinary chloride ion concentration was measured. Sodium excretion was not determined. Measuring urinary chloride concentration alone gives a false conception of sodium losses. A greater proportion of the chloride ion than of the sodium ion in the extracellular fluid is excreted in the urine after the administration of mercurials, apparently because such agents act primarily on the chloride ion.7 All the subjects showed significantly positive daily water balance, and, in all cases but one, mercurial diuretics were administered very infrequently and intermittently. Only one of the cases reported showed a significant diuresis as judged by weight loss, after the administration of hypertonic saline solution to correct the electrolyte imbalance. Many did not lose as much weight after therapy as they had gained during their period of oliguria. For these reasons all the cases could represent examples of extracellular fluid expansion with electrolyte dilution, and no direct evidence is presented to iiicriminiate mercurial diuretics as etiologic agents. To state unequivocally that hyponatremia results from the administration of mercurial diuretics, it should be necessary to show that urinary sodium ( concentrations in the diuresis following drug administration exceeds the plasma concentration of sodium, in a setting where the fluid intake is restricted to approximate the patient's insensible loss (e.g., 1 kilogram of weight loss is equivalent to 1 L. of urine output). To our knowledge, this has unever been demonstrated.
In our experience, most patients with refractory edema due to heart failure have normal plasma electrolyte concentrations.8 At this stage in the natural history of their heart disease, these patients are unable to handle water as well as salt. This is not generally appreciated, and while salt intake is rigidly restricted, fluid intake is not. The result is fluid retention, further expansion of extracellular fluid volume, and consequently electrolyte dilution.
Overhydration with resultant expansion of the extracellular fluid volume and dilution of electrolytes would appear to be the most important etiologic factor in the production of this syndrome, which might better be termed the "dilution syndrome."
In 25 refractory cardiac patients with normal plasma sodium and chloride concentrations in whom a hyperchloremic acidosis was produced by means of Diamox (acetazokamide) and ammonium chloride,8 a responsiveness to mercurial diuretics was restored. In all these patients the urinary sodium concentration during the mercurial-induced diuresis was It appeared to us, developing the premise that this syndrome represented a primary dilution phenomenon, that the aim in therapy should be the mobilization of excess fluid ill the expanded extracellular fluid space, rather than elevation of the extracellular fluid sodium ( ontent. Accordingly, a group of five patients with heart disease, congestive failure, and refractory fluid retentioni, who showed azotemia, oliguria, anorexia, amid nausea, and who had a marked hyponatremia and hypochloremia were treated with a regimen that had been successful in restoring responsiveness to mercurial diuretics in cardiac patients with refractory fluid retention who had normal plasma electrolyte patterns. This regimen, which utilizes Diamox and aqueous ammonium chloride, has previously been described in detail. The patient was initially treated with complete bed rest, 1 Gin. salt diet, oxygen, phlebotomy, and was given additional digitalis until minor toxic symptoms appeared. Despite these measures, he showed no improvement. Table 2 is a tabulation of the daily weight, intake and output, plasma and urine electrolyte concentration, and medications given in this case. After 10 days his weight had risen, and his urine output had fallen below 1000 ml. per day. The blood urea nitrogen was 67 mg. per cent. The plasma sodium had fallen to 122 mEq. and the plasma chloride to 87 mEq. per liter.
During the next 2 weeks, 5 per cent hypertonic saline was administered intravenously in amounts of 100 to 200 ml. on 6 different occasions in an attempt to correct the hyponatremia and hypochloremia. At the end of this period the patient had gained 13 pounds, showed anasarca, and was symptomatically worse. Plasma sodium concentration was 112 mEq. and plasma chloride concentration was 98 mEq. per liter.
At this time, a review of the patient's clinical course showed that in this 20-day period, a significantly positive daily water balance was present. Fluid intake had averaged 2300 ml. daily, while his urine output averaged 800 ml. daily. During this period, the patient had been afebrile and had not perspired excessively. The major factor in his hyponatremia and hypochloremia was felt to be dilution, and it was decided that therapy should be directed primarily toward mobilization of this excess total body water. Accordingly, the patient was given 750 mg. of Diamox in a single dose by mouth and 10 Gm. of aqueous ammonium chloride in 5 divided doses daily for 4 days. Fluid intake was restricted to approximate his urine output plus estimated insensible loss. During this 4-day period of Diamox and ammonium chloride administration, his weight did not change. A hyperchloremic acidosis was produced. The plasma pH fell from 7.43 to 7.27 and plasma chloride rose from 94 to 114 mEq. per liter. Carbon dioxide combining power fell from 22.6 to 8.4 mai per liter. No symptoms of acidosis developed. Plasma sodium remained low at 120 mEq. per liter, and plasma potassium stayed within normal limits. Urine output averaged 850 ml. daily with very low-sodium content. Urine chloride content, initially low, rose as the plasma chloride level increased (table 2 and fig. 1 ).
In this setting of a hyponatremia and hyperchloremic acidosis, Mercuhydrin (2 ml. intramuscularly) was TREATMENT OF LOW-SALT SYNDROME IN CONGESTIVE HEART FAILURE increased despite mercurial injections twice a week. During this period his fluid intake was high and salt intake was drastically curtailed.
Physical examination on admission revealed a blood pressure of 180/110, pulse 100 (regular), rate 30 per minute, temperature 37.2 C. He seemed both acutely and chronically ill, and was disoriented, dyspneic, and cyanotic. There was grade III retinopathy. Neck veins were distended. The chest had an increased anteroposterior diameter, was hyperresonant to percussion, had diminished tactile fremitus, and fine, medium, and coarse rales throughout. His heart was enlarged to the anterior axillary line, and an apical systolic murmur was present. The liver was felt 5 With the history of salt restriction, oliguria, weight gain, and high fluid intake, it was felt that the hyponatremia was the result of dilution rather than inordinate urinary losses of salt. Table 3 lists the daily weight, intake and output, plasma and urine electrolyte concentrations, and medications given in this case.
The patient was placed on bronchodilators, bed The effectiveness of this therapeutic approach, directed primarily toward reducing the expanded extracellular fluid voluime, and not primarily toward increasing the sodium content of the extracellular fluid, supports the postulation that the mechanism for development of this syndrome is primarily fluid retention with extracellular fluid expansion, and not salt depletion. In keeping with this view is the role that mercurial diuretics play in the success of this regimen, when heretofore they have beei purported to be a significant causative factor in producing the "low-salt" syndlrome.
C: ONCLLUSIONS
]. An effective regimen for treatment of the "loN-salt syndrome" utilizing Diamox, ammoinium chloride, aild mercurial diuretics has been presented. 2 . It is suggested that extracellular fluid cxpansion with electrolyte dilution is the major factor in the production of the "low-salt syndrome," which might more aptly be termed the "dilution syndrome."
